全文获取类型
收费全文 | 768篇 |
免费 | 66篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 57篇 |
妇产科学 | 13篇 |
基础医学 | 124篇 |
口腔科学 | 10篇 |
临床医学 | 75篇 |
内科学 | 162篇 |
皮肤病学 | 21篇 |
神经病学 | 87篇 |
特种医学 | 21篇 |
外科学 | 102篇 |
综合类 | 8篇 |
预防医学 | 62篇 |
眼科学 | 8篇 |
药学 | 39篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 8篇 |
2022年 | 17篇 |
2021年 | 26篇 |
2020年 | 12篇 |
2019年 | 16篇 |
2018年 | 11篇 |
2017年 | 15篇 |
2016年 | 17篇 |
2015年 | 22篇 |
2014年 | 21篇 |
2013年 | 35篇 |
2012年 | 43篇 |
2011年 | 37篇 |
2010年 | 31篇 |
2009年 | 25篇 |
2008年 | 39篇 |
2007年 | 40篇 |
2006年 | 48篇 |
2005年 | 39篇 |
2004年 | 31篇 |
2003年 | 45篇 |
2002年 | 32篇 |
2001年 | 26篇 |
2000年 | 24篇 |
1999年 | 26篇 |
1998年 | 14篇 |
1997年 | 13篇 |
1996年 | 6篇 |
1995年 | 10篇 |
1993年 | 3篇 |
1992年 | 10篇 |
1991年 | 11篇 |
1990年 | 8篇 |
1989年 | 8篇 |
1988年 | 8篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 8篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1974年 | 4篇 |
1972年 | 2篇 |
1971年 | 3篇 |
1970年 | 3篇 |
1969年 | 4篇 |
1958年 | 1篇 |
1912年 | 2篇 |
排序方式: 共有838条查询结果,搜索用时 15 毫秒
81.
Ethanol Produces Corticotropin‐Releasing Factor Receptor‐Dependent Enhancement of Spontaneous Glutamatergic Transmission in the Mouse Central Amygdala
下载免费PDF全文
![点击此处可从《Alcoholism, clinical and experimental research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
82.
83.
84.
85.
W. Scheithauer G. Kornek M. Raderer K. Koperna-Mach C. Müller J. Karner J. Kastner C. Tetzner 《Journal of cancer research and clinical oncology》1995,121(Z3):R7-R10
A group of 28 previously untreated patients with locally advanced or metastatic adenocarcinoma of the pancreas were entered
in this phase I/II study. Treatment consisted of oral dexverapamil 1000–1200 mg/day for 3 days, epirubicin given as an intravenous
bolus injection on day 2 with a starting dose of 90 mg/m2, and 400 μg granulocyte/macrophage-colony-stimulating factor (GM-CSF) administered subcutaneously from day 5 through 14.
Epirubicin dose escalation levels were 90, 105, 120 and 135 mg/m2. Consecutive cohorts of 4–8 patients were planned at each dose level. Treatment cycles were repeated every 3 weeks. Haematological
toxicity, specifically granulocytopenia constituted the dose-limiting toxicity with a maximum tolerated dose of 120 mg/m2 for epirubicin. Despite routine supportive therapy with GM-CSF, 4, 2, and 5 patients experienced grade 4 granulocytopenia
during their first two treatment courses at levels of 105, 120, and 135 mg/m2 respectively. Non-haematological toxicity was uncommon, generally modest, and did not demonstrate a clear relationship with
the anthracycline dose. Dexverapamil-related cardiovascular symptoms occurred frequently, but they never resulted in serious
toxicity requiring active medical intervention or permanent discontinuation of therapy. Of the 28 patients, 9 achieved partial
responses to this therapy. The recommended dose of epirubicin for this regimen with dexverapamil and GM-CSF is 120 mg/m2 every 3 weeks. Therapeutic results suggest this regimen to be an effective and tolerable treatment strategy in pancreatic
cancer, which should be evaluated further. 相似文献
86.
A 35-year-old man with a history of polyarteritis nodosa is presented. The patient presented with acute anterolateral myocardial infarction that was complicated by diffuse coronary artery aneurysms found during cardiac catheterization. The complication of acute myocardial infarction in a patient with diffuse coronary artery aneurysms associated with polyarteritis nodosa is rare. 相似文献
87.
88.
Diaz A Hu C Kastner DL Schaner P Reginato AM Richards N Gumucio DL 《Arthritis and rheumatism》2004,50(11):3679-3689
89.
Prediction of early-onset asthma in genetically at-risk children 总被引:4,自引:0,他引:4
Mrazek DA Klinnert M Mrazek PJ Brower A McCormick D Rubin B Ikle D Kastner W Larsen G Harbeck R Jones J 《Pediatric pulmonology》1999,27(2):85-94
The W.T. Grant Foundation Asthma Risk Study was designed to prospectively examine children who were considered at a genetically increased risk for the development of asthma. The respective contributions of 11 potential risk factors, both environmental and biological, were assessed in order to determine their relative roles in affecting the early onset of asthma. This is a report of an inception cohort of children born to asthmatic mothers and followed for a 3-year period. All 150 families were recruited from the general community and living within 2 h of the National Jewish Center for Immunology and Respiratory Medicine (Denver, CO). Mothers in the index risk sample had been previously diagnosed with asthma and were recruited during their pregnancy through physician referrals and media solicitation. The index sample of 150 families was 92% Caucasian and predominantly middle class. The mean age of mothers was 29.3 years, and of fathers, 31.1 years. The main outcome was the determination of the early onset of asthma and its association with quantified risk factors. By age 3 years, 14 of the 150 children had developed asthma. Frequent illness, IgE levels at age 6 months, parenting difficulties, and early eczema were significantly associated with the onset of asthma (P = 0.003, P = 0.006, P = 0.01, and P = 0.03, respectively). Only frequent illness, elevated serum IgE levels, and parenting difficulties entered a predictive model where they were independently related to the development of asthma. 相似文献
90.